Anti-NMDAR encephalitis in 10-year-old girl
Sanglah Hospital, Bali, Indonesia
DOI:
https://doi.org/10.29332/ijhs.v5n1.600Keywords:
anti-NMDAR, children, encephalitis, neuropsychiatry, syndromeAbstract
Anti-NMDAR encephalitis is a central nervous system (CNS) disease involving dysfunction of the autoimmune system. Anti-NMDAR encephalitis is an immune-mediated disease characterized by a complex neuropsychiatric syndrome and the presence of CSF antibodies against the GluN1 subunit of the NMDAR. The diagnosis was by history taking, physical examination, and antibody NMDAR for definitive diagnosis. Principal management is starting therapy earlier may lead to better outcomes. A 10-year-old girl was admitted to Sanglah Hospital, with a complaint of seizure with the characteristic of the seizure was head-turning to the left side then continue to stiff extremities and body, involved stiffening and jerking, both eyes glared up, and unconscious. A Head CT scan showed no signs of hemorrhage, intracerebral or intracerebellar space-occupying lesion, hypertrophy chance nasal inferior bilateral, blurring in grey-white matter junction regio right parietal lobus with narrowing of right lateral ventricle, suspected right hemisphere edema. MRA showed no signs of the infarct, hemorrhage, or space-occupying lesion, with normal anterior and posterior arterial cerebri system. Anti-NMDAR serum was positive. The patient was treated with high-dose methylprednisolone and planned to get cyclophosphamide. Anti-NMDAR encephalitis is a disease with the challenging diagnosis of neuropsychiatric syndrome in children.
Downloads
References
Armangue, T., Petit-Pedrol, M., & Dalmau, J. (2012). Autoimmune encephalitis in children. Journal of child neurology, 27(11), 1460-1469.
Armangue, T., Titulaer, M. J., Málaga, I., Bataller, L., Gabilondo, I., Graus, F., ... & Anti-N-methyl-D-Aspartate, S. (2013). Pediatric anti-N-methyl-D-aspartate receptor encephalitis—clinical analysis and novel findings in a series of 20 patients. The Journal of pediatrics, 162(4), 850-856. https://doi.org/10.1016/j.jpeds.2012.10.011
Barry, H., Byrne, S., Barrett, E., Murphy, K. C., & Cotter, D. R. (2015). Anti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment. BJPsych Bulletin, 39(1), 19-23.
Cruz, A. T., Lane, R. D., Balamuth, F., Aronson, P. L., Ashby, D. W., Neuman, M. I., ... & Schlapbach, L. J. (2020). Updates on pediatric sepsis. Journal of the American College of Emergency Physicians Open, 1(5), 981-993.
Dalmau, J., Armangué, T., Planagumà, J., Radosevic, M., Mannara, F., Leypoldt, F., ... & Graus, F. (2019). An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. The Lancet Neurology, 18(11), 1045-1057. https://doi.org/10.1016/S1474-4422(19)30244-3
Dalmau, J., Gleichman, A. J., Hughes, E. G., Rossi, J. E., Peng, X., Lai, M., ... & Lynch, D. R. (2008). Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. The Lancet Neurology, 7(12), 1091-1098. https://doi.org/10.1016/S1474-4422(08)70224-2
Dalmau, J., Lancaster, E., Martinez-Hernandez, E., Rosenfeld, M. R., & Balice-Gordon, R. (2011). Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. The Lancet Neurology, 10(1), 63-74. https://doi.org/10.1016/S1474-4422(10)70253-2
Dalmau, J., Tüzün, E., Wu, H. Y., Masjuan, J., Rossi, J. E., Voloschin, A., ... & Lynch, D. R. (2007). Paraneoplastic anti–N?methyl?D?aspartate receptor encephalitis associated with ovarian teratoma. Annals of neurology, 61(1), 25-36.
Florance-Ryan, N., & Dalmau, J. (2010). Update on anti-N-methyl-D-aspartate receptor encephalitis in children and adolescents. Current opinion in pediatrics, 22(6), 739-744.
Goenka, A., Jain, V., Nariai, H., Spiro, A., & Steinschneider, M. (2017). Extended clinical spectrum of anti–N-Methyl-d-Aspartate receptor encephalitis in children: a case series. Pediatric neurology, 72, 51-55. https://doi.org/10.1016/j.pediatrneurol.2017.03.010
Granata, T., Matricardi, S., Ragona, F., Freri, E., Zibordi, F., Andreetta, F., ... & Nardocci, N. (2018). Pediatric NMDAR encephalitis: a single center observation study with a closer look at movement disorders. european journal of paediatric neurology, 22(2), 301-307. https://doi.org/10.1016/j.ejpn.2018.01.012
Granerod, J., Ambrose, H. E., Davies, N. W., Clewley, J. P., Walsh, A. L., Morgan, D., ... & UK Health Protection Agency (HPA) Aetiology of Encephalitis Study Group. (2010). Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. The Lancet infectious diseases, 10(12), 835-844. https://doi.org/10.1016/S1473-3099(10)70222-X
Graus, F., Titulaer, M. J., Balu, R., Benseler, S., Bien, C. G., Cellucci, T., ... & Dalmau, J. (2016). A clinical approach to diagnosis of autoimmune encephalitis. The Lancet Neurology, 15(4), 391-404. https://doi.org/10.1016/S1474-4422(15)00401-9
Luca, N., Daengsuwan, T., Dalmau, J., Jones, K., deVeber, G., Kobayashi, J., ... & Benseler, S. M. (2011). Anti–N?methyl?D?aspartate receptor encephalitis: A newly recognized inflammatory brain disease in children. Arthritis & Rheumatism, 63(8), 2516-2522.
McCarthy, M. S., & Martindale, R. G. (2018). Immunonutrition in critical illness: what is the role?. Nutrition in Clinical Practice, 33(3), 348-358.
Remy, K. E., Custer, J. W., Cappell, J., Foster, C. B., Garber, N. A., Walker, L. K., ... & Bagdure, D. (2017). Pediatric anti-N-methyl-d-aspartate receptor encephalitis: a review with pooled analysis and critical care emphasis. Frontiers in Pediatrics, 5, 250.
Sai, Y., Zhang, X., Feng, M., Tang, J., Liao, H., & Tan, L. (2018). Clinical diagnosis and treatment of pediatric anti N methyl D aspartate receptor encephalitis: A single center retrospective study. Experimental and therapeutic medicine, 16(2), 1442-1448.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
